CRL
NYSE · Life Sciences Tools & Services
Charles River Laboratories
$177.62
-4.06 (-2.23%)
Analyst Consensus
Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
-59.9% upside
Low Target
$57.45
Average Target
$71.21
High Target
$105.86
Current Price
$177.62
Current
$177.62
$177.62
Target
$71.21
$71.21
$57.45
$71.21 avg
$105.86
Scenario Analysis
Bear Case
$57.45
-67.7%
Low target
Base Case
$71.21
-59.9%
Avg target
Bull Case
$105.86
+-40.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$228.88
-22.4% from high
52-Week Low
$131.30
+35.3% from low
50-Day SMA
$200.46
-11.4% vs SMA
200-Day SMA
$169.92
+4.5% vs SMA
RSI (14)
21.1
Oversold
Target vs 52W High
$71.21
-68.9% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 88% | $369.21 | -20.6% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -7.6% |
| WAT | Buy | 28 | 57% | $189.60 | -46.6% |
| A | Strong Buy | 28 | 79% | $64.69 | -44.0% |
| IQV | Strong Buy | 31 | 87% | $82.96 | -53.6% |
| MTD | Hold | 21 | 48% | $170.43 | -84.8% |
| WST | Strong Buy | 23 | 78% | $136.24 | -58.2% |
| ILMN | Hold | 28 | 54% | $169.36 | +19.4% |